2025 ASH ISTH NBDF WFH monitoring report Confirms Strength of 2021 VWD Diagnosis and Management Guidelines
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared on X:
”2025 ASH ISTH NBDF WFH monitoring report on the 2021 clinical guidelines on the diagnosis and management of von Willebrand disease. None of the reviewed studies would change the direction or strength of the existing guideline recommendations.”
Read the full article here.
A comprehensive review of recent literature assessed whether updates are needed for the ASH ISTH NHF WFH 2021 guidelines on the diagnosis and management of von Willebrand disease (VWD).
Of 432 studies screened for diagnosis and 288 for management, a subset underwent full text review, but none provided evidence strong enough to alter the current recommendations in direction or strength.
As VWD remains the most common inherited bleeding disorder, continued monitoring of emerging data is planned to ensure the guidelines remain current and evidence-based.
Find latest scientific updates on von Willebrand disease featured in Hemostasis Today.
-
Aug 31, 2025, 14:26Diego Segura-Rodríguez Shares ESC/EACTS Consensus on Post-CABG Antithrombotic Therapy
-
Aug 31, 2025, 09:45Slow Uptake of Hemophilia Gene Therapies: Challenges in Access and Adoption
-
Aug 30, 2025, 14:43Abdulla A. Damluji Questions Evidence for Beta-Blockers After MI Without Heart Failure
-
Aug 30, 2025, 14:42BDCC Future Leaders ’26: Empowering Teens Like Sarada Venigalla to Share Their Stories
-
Aug 30, 2025, 14:39Michael Makris Shares French Regulatory Update: Marstacimab (Hympavzi) Not Recommended for Severe Haemophilia A or B
-
Aug 31, 2025, 12:39Lupus Anticoagulant and Antiphospholipid Syndrome: Insights from Local Practice
-
Aug 31, 2025, 10:55NEJM Study: Aspirin with Oral Anticoagulation Raises Risks in Chronic Coronary Syndrome
-
Aug 31, 2025, 07:29Marcin Kurzyna: ESC Guidelines on Pregnancy and Cardiovascular Disease Highlight Updates in VTE Treatment
-
Aug 30, 2025, 14:44Sarah C. Hull: Evidence Supports Plant-Forward Diets, Not Raw Milk or Beef Tallow Trends
-
Aug 30, 2025, 14:43Extended Low-Dose Apixaban Reduces Risk of Recurrent VTE: HI-PRO Trial Results
-
Aug 29, 2025, 09:03Vasculearn Network: New 2025 High Blood Pressure Guidelines Are Here
-
Aug 18, 2025, 23:56Dr. Arun V. J Invites You to His Lecture on ‘AI and Data Sciences in Transfusion Medicine’ at the AI in Healthcare Conclave. Register now!
-
Aug 18, 2025, 23:50Safe and Efficient Thrombectomy with Artix System: Clinical Insights from Neil Desai and Colleagues
-
Aug 16, 2025, 14:42Mark Crowther Honors Davide Matino for Leading Promising Hemophilia Trial at McMaster University
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Aug 30, 2025, 14:45Gordon’s Journey: 60 Years of Life After DVT Managed with Warfarin
-
Aug 29, 2025, 19:10Mount Sinai’s Dr. Krittika Pant to Present Watchman Device Thrombosis Analysis at ESC Congress 2025
-
Aug 29, 2025, 09:02Flora Peyvandi: Join the Hemostasis Community at BIC 2025 in Italy
-
Aug 26, 2025, 09:42David McIntosh Highlights Global Blood Shortages and Fresh vs Stored RBCs
-
Aug 23, 2025, 07:48Protecting Heart and Brain Health: Stroke Prevention in Women with Bleeding Disorders: NBDF